Sildenafil for pulmonary hypertension in pregnancy? [13]

Anesthesiology

Volumn 104, Issue 2, 2006, Pages 382-

  Lynch, Tadhg D ^a   Laffey, John G ^b  

^a UNIVERSITY HOSPITAL GALWAY   (Ireland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ILOPROST; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHOSPHODIESTERASE V INHIBITOR; SILDENAFIL; PHOSPHODIESTERASE INHIBITOR; PIPERAZINE DERIVATIVE; VASODILATOR AGENT;

ARTERIAL OXYGEN SATURATION; CLINICAL TRIAL; DOWN REGULATION; DRUG EFFICACY; DRUG SAFETY; ENZYME REGULATION; HEART FAILURE; HUMAN; HYPOXIA; ISCHEMIC HEART DISEASE; LETTER; LUNG ARTERY PRESSURE; LUNG BLOOD VESSEL; LUNG CIRCULATION; PREGNANCY; PREMATURITY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; TERATOGENICITY; UNSPECIFIED SIDE EFFECT; VASCULAR SMOOTH MUSCLE; VASODILATATION; ADULT; FEMALE; NOTE; PREGNANCY COMPLICATION;

ADULT; FEMALE; HUMANS; HYPERTENSION, PULMONARY; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; VASODILATOR AGENTS;

EID: 33644948639     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/00000542-200602000-00037     Document Type: Letter

References (22)

1. Bonnin M, Mercier FJ, Sitbon O, Roger-Christoph S, Jais X, Humbert M, Audibert F, Frydman R, Simonneau G, Benhamou D: Severe pulmonary hypertension during pregnancy: Mode of delivery and anesthetic management of 15 consecutive cases. ANESTHESIOLOGY 2005; 102:1133-7
2. Preston IR, Klinger JR, Houtches J, Nelson D, Farber HW, Hill NS: Acute and chronic effects of sildenafil in patients with pulmonary arterial hypertension. Respir Med 2005; 99:1501-10
3. Ghofrani HA, Wiedemann R, Rose F, Schermuly RT, Olschewski H, Weissmann N, Gunther A, Walmrath D, Seeger W, Grimminger F: Sildenafil for treatment of lung fibrosis and pulmonary hypertension: A randomised controlled trial. Lancet 2002; 21:360:895-900
4. Sastry BK, Narasimhan C, Reddy NK, Raju BS: Clinical efficacy of sildenafil in primary pulmonary hypertension: A randomized, placebo-controlled, double-blind, crossover study. J Am Coll Cardiol 2004; 43:1149-53
5. Richalet JP, Gratadour P, Robach P, Pham I, Dechaux M, Joncquiert-Latarjet A, Mollard P, Brugniaux J, Cornolo J: Sildenafil inhibits altitude-induced hypoxemia and pulmonary hypertension. Am J Respir Crit Care Med 2005; 171:275-81
6. Zhao L, Mason NA, Morrell NW, Kojonazarov B, Sadykov A, Maripov A, Mirrakhimov MM, Aldashev A, Wilkins MR: Sildenafil inhibits hypoxia-induced pulmonary hypertension. Circulation 2001; 104:424-8
7. Molelekwa V, Akhter P, McKenna P, Bowen M, Walsh K: Eisenmenger's syndrome in a 27 week pregnancy-management with bosentan and sildenafil. Ir Med J 2005; 98:87-8
8. Lacassie HJ, Germain AM, Valdes G, Fernandes MS, Allamand F, Lopez H: Management of Eisenmenger syndrome in pregnancy with sildenafil and L-arginine. Obstet Gynecol 2004; 103:1118-20
9. Zhao L, Mason NA, Morrell NM, Kojonazarov B, Sadykov A, Maripov A, Mirrakhimov MM, Aldashev A, Wilkins MR: Sildenafil inhibits hypoxia-induced pulmonary hypertension. Circulation 2001; 104:424-8
10. Dishy V, Sofowora G, Harris PA, Kandcer M, Zhan F, Wood AJ, Stein CM: The effect of sildenafil on nitric oxide mediated-vasodilation in healthy men. Clin Pharmacol Ther 2001; 70:270-9
11. Ghofrani HA, Voswinckel R, Reichenberger F, Olschewski H, Haredza P, Karadas B, Schermuly RT, Weissmann N, Seeger W, Grimminger F: Differences in hemodynamic and oxygenation responses to three different phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension: A randomized prospective study. J Am Coll Cardiol 2004; 44:1488-96
12. Bush HS: Safe use of sildenafil in patients with coronary artery disease. Cleveland Clin J Med 2001; 68:349-52
13. Shakar SF, Bristow MR: Low level inotropic stimulation with type III phosphodiesterase inhibitors in patients with advanced symptomatic heart failure receiving beta-blocking agents. Curr Cardiol Rep 2001; 3:224-31
14. Wilkens H, Guth A, Konig J, Forestier N, Cremers B, Hennen B, Bohm M, Sybrecht GW: Effect of inhaled iloprost plus oral sildenafil in patients in patients with primary pulmonary hypertension. Circulation 2001; 104:1218-22
15. Ghofrani HA, Wiedemann R, Rose F, Olschewski H, Schermuly RT, Weissmann N, Seeger W, Grimminger F: Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension. Ann Intern Med 2002; 136:515-22
16. Michelakis E, Tymchak W, Lein D, Webster L, Hashimoto K, Archer S: Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension: Comparison with inhaled nitric oxide. Circulation 2002; 105:2398-403
17. Lepore JJ, Maroo A, Bigatello LM, Dec GW, Zapol WM, Bloch KD, Semigran MJ: Hemodynamic effects of sildenafil in patients with congestive heart failure and pulmonary hypertension: Combined administration with inhaled nitric oxide. Chest 2005; 127:1647-53
18. Ghofrani HA, Rose F, Schermuly RT, Olschewski H, Wiedemann R, Weissmann N, Schudt C, Tenor H, Seeger W, Grimminger F: Amplification of the pulmonary vasodilatory response to inhaled iloprost by subthreshold phosphodiesterase type 3 and 4 inhibition in severe pulmonary hypertension. Crit Care Med 2002; 30:2489-92
19. Mychaskiw G, Sachdev V, Heath BJ: Sildenafil (Viagra) facilitates weaning of inhaled nitric oxide following placement of a biventricular-assist device. J Clin Anesth 2001; 13:218-20
20. Sher G, Fisch JD: Effect of vaginal sildenafil on the outcome of in vitro fertilization (IVF) after multiple IVF failures attributed to poor endometrial development. Fertil Steril 2002; 78:1073-6
21. Karatza AA, Bush A, Magee AG: Safety and efficacy of sildenafil therapy in children with pulmonary hypertension. Int J Cardiol 2005; 100:267-73
22. Travadi JN, Patole SK: Phosphodiesterase inhibitors for persistent pulmonary hypertension of the newborn: A review. Pediatr Pulmonol 2003; 36:529-35